In this interview, Dr. Ashley Tapscott, a board-certified urologist and an established expert in sexual dysfunction, talks about current treatment options and novel therapies for overactive bladder. Specifically, the discussion focuses on GEMTESA®(vibegron), a beta-3 agonist that works by relaxing the bladder muscle, thereby allowing it to hold more urine. ...
Advertisement
Latest News
A study found unique risk factors for cardiovascular disease and mortality in patients with age-related macular degeneration.
The CardioNerds ponder another important question related to heart failure with Dr. Shelley Zieroth.
US veterans who were exposed to Agent Orange have an increased risk of myeloproliferative neoplasms.
The novel JAK1-sparing inhibitor pacritinib is effective at reducing spleen enlargement and disease burden in MF patients.
The safety and efficacy of luspatercept is favorable for treating anemia in patients with myelofibrosis.
Patients admitted for atrial fibrillation who have myeloproliferative neoplasms have an increased risk of bleeding.
DocWire Content Partners
Get insights for cardiologists from the CardioNerds.
Fundamentals, core concepts, and important management approaches in the field of hematology and oncology
Dr. Chadi Nabhan discusses medical advances with renowned experts.
Drs. Rohit Gosain and Rahul Gosain discuss practice-changing data and standards of oncology care.
Dr. Hady Lichaa is an interventional cardiologist specializing in complex coronary interventions.
Expert interviews with Dr. Payal Kohli
